DHX15 and Burkitt lymphoma: In this study, we found that DHX15 promoted cell proliferation and tumor growth, inhibited cell apoptosis, and increased the expression of type I EBV latent infection products, suggesting that DHX15 might play an important role in pathogenesis of BL and be a potential therapeutic target for treating BL.